Tissue-engineeredproductSupplementaryprotectioncertificateRapporteurSpecificobligationsThirdcountryWorkingpartyRegulatoryauthorityType IIvariationRe-examinationType IAvariationTransfer ofmarketingauthorisationProduct-specificwaiverReferenceMemberStateRiskminimisationactivityProtocolassistanceWorksharingWithdrawalperiodWell-establisheduseSubgroupanalysisSummaryof opinionSpecimenRenewalTrialprotocolRiskmanagementsystemSummary ofproductcharacteristicsVariationRiskmanagementplanSunsetclauseScientificadviceProductinformationSomaticcell basedmedicineScientificadvisorygroupReflectionpaperRoute ofadministrationSeriousadversereactionType IBvariationSafetysignalUrgentsafetyrestrictionReferralRequest forsupplementaryinformationTissue-engineeredproductSupplementaryprotectioncertificateRapporteurSpecificobligationsThirdcountryWorkingpartyRegulatoryauthorityType IIvariationRe-examinationType IAvariationTransfer ofmarketingauthorisationProduct-specificwaiverReferenceMemberStateRiskminimisationactivityProtocolassistanceWorksharingWithdrawalperiodWell-establisheduseSubgroupanalysisSummaryof opinionSpecimenRenewalTrialprotocolRiskmanagementsystemSummary ofproductcharacteristicsVariationRiskmanagementplanSunsetclauseScientificadviceProductinformationSomaticcell basedmedicineScientificadvisorygroupReflectionpaperRoute ofadministrationSeriousadversereactionType IBvariationSafetysignalUrgentsafetyrestrictionReferralRequest forsupplementaryinformation

Regulatory Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
  1. Tissue-engineered product
  2. Supplementary protection certificate
  3. Rapporteur
  4. Specific obligations
  5. Third country
  6. Working party
  7. Regulatory authority
  8. Type II variation
  9. Re-examination
  10. Type IA variation
  11. Transfer of marketing authorisation
  12. Product-specific waiver
  13. Reference Member State
  14. Risk minimisation activity
  15. Protocol assistance
  16. Worksharing
  17. Withdrawal period
  18. Well-established use
  19. Subgroup analysis
  20. Summary of opinion
  21. Specimen
  22. Renewal
  23. Trial protocol
  24. Risk management system
  25. Summary of product characteristics
  26. Variation
  27. Risk management plan
  28. Sunset clause
  29. Scientific advice
  30. Product information
  31. Somatic cell based medicine
  32. Scientific advisory group
  33. Reflection paper
  34. Route of administration
  35. Serious adverse reaction
  36. Type IB variation
  37. Safety signal
  38. Urgent safety restriction
  39. Referral
  40. Request for supplementary information